Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doppler Modifications in Intrauterine Growth Restricted Fetuses
NL-OMON43435Withdrawn
- Sponsor
- NVOG
- Start
- May 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of betamethasone in intrauterine growth restriction (IUGR), sponsored by NVOG. Planned start May 2021; status: withdrawn.
02
Drugs
betamethasone
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on NL-OMON43435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43435.